Hi, I'm Dr Sachin Jadhav
MD, DM (Clinical Hematology)
Director of Hematology and Bone Marrow Transplant (BMT)
Chairman International Hematology Consortium
My Professional Work
Dr. Sachin Jadhav is presently the Director of Hematology and Bone Marrow Transplantation (BMT) at Trustwell Hospitals Pvt Ltd. With extensive experience in founding and managing BMT centers, he has successfully established 14 such centers since 2013. Additionally, Dr. Jadhav serves as the CEO of Chiron Cancer, where he focuses on creating accessible cancer and BMT facilities across multiple countries. He plays an active role in several prestigious professional organizations, including ASTCT, ASH, and AAAS, and holds various leadership positions such as International Ambassador for the CGC.
Hematology & Bone Marrow Transplantation
Hematology and bone marrow transplantation department is a well-equipped unit of experienced and skilled hematologists and BMT experts who are specialised in the diagnosis and management of a wide range of benign and malignant disorders of blood and bone marrow.
Treatments Available for Following Conditions
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL) is a cancer of the bone marrow and blood, characterized by the rapid production of immature white blood cells.
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML) is a fast-growing cancer of the bone marrow and blood, characterized by the uncontrolled growth of abnormal myeloid cells.
Chronic Lymphocytic Leukemia (CLL/SLL)
Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) is a slow-growing cancer of the blood and bone marrow, involving the accumulation of abnormal white blood cells.
Chronic Myeloid Leukemia (CML)
Chronic Myeloid Leukemia (CML) is a type of cancer that starts in the blood-forming cells of the bone marrow and leads to the overproduction of mature and immature white blood cells.
Polycythemia
Polycythemia is a condition characterized by an increased number of red blood cells in the bloodstream, leading to thicker blood and a higher risk of clotting, stroke, or heart attack.
Myelofibrosis
Myelofibrosis is a rare bone marrow disorder where scar tissue forms in the marrow, disrupting blood cell production and leading to anemia, fatigue, and an enlarged spleen or liver.
Essential Thrombocytosis/Thrombocythemia
Essential thrombocytosis (or thrombocythemia) is a rare blood disorder characterized by an abnormally high platelet count, increasing the risk of blood clots or bleeding complications.
Myelodysplastic syndrome (MDS)
Myelodysplastic syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells in the bone marrow, often leading to anemia, infections, and bleeding.
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition where the immune system overreacts, leading to severe inflammation and organ damage.
Bone Marrow Transplant
Bone marrow transplant is a medical procedure that replaces the destroyed or damaged bone marrow cells with healthy bone marrow cells. It involves the extraction of healthy bone marrow cells, filtration and transferring them back to the donor itself (Autologous Transplant) or to another individual, who is called the recipient. (Allogenic Transplant)
Why is Bone Marrow Transplant required?
The goal of bone marrow transplant is to improve quality of life and cure many benign diseases and a few types of cancer successfully. For some diseases, a bone marrow transplant serves as the only potential cure.
A bone marrow transplant becomes necessary when:
- The existing bone marrow cells are damaged, destroyed or not functioning optimally due to health conditions such as aplastic anaemia, leukaemia, etc. A bone marrow transplantation in this case helps patients have a healthy, functioning marrow.
- The immune system needs to be regenerated to fight the existing or residual cancers that could not be treated completely with radiation or chemotherapy.
Treatments Provided
Clinical Trials & Research
Bone Marrow Transplant (BMT)/Stem Cell Transplant (SCT)
Neutropenic infections
Blood Cancers
Clinical Attachment Great Ormond Street Hospital, London, UK - 2013
Fellowship (Leukemia/BMT) University of British Columbia, Vancouver, Canada - 2012
DM (Clinical Hematology) CMC, Vellore - 2011
MD (Internal Medicine) BJ Medical College, Pune - 2004
MBBS Rajiv Gandhi Medical College, Thane - 2001
PhD Management Sciences Amrita School of Business, Bengaluru - Ongoing
Strategic Change Management IIM, Bangalore 2021
Mastering Design Thinking MIT Sloan 2021 MIT Sloan - 2021
Management Essentials Harvard Business School - 2021
My Work Experience
Dr. Sachin Suresh Jadhav is a highly esteemed professional in the field of Hematology and Blood and Marrow Transplantation (BMT)
Trustwell Hospitals Pvt Ltd
July 2024 to present
Marrow Matters Pvt. Ltd.
October 2017 to present
HCG Group of Hospitals
August 2019 to Jan 2024
Meitra Hospital, Calicut
April 2019 to July 2019
Fortis Hospitals, Bengaluru
October 2017 to May 2019
Global Hospital Group, India
February 2013 to October 2017
My Publications
1. Basavaraj A., Sachin Suresh Jadhav. Familial hypercholesterolemia presenting as intracranial xanthoma. A case report Journal of the Association of Physicians of India. 2006
2. AuroViswabandya and Sachin Suresh Jadhav. Management of classical Hodgkin lymphoma: utility of PET scanning. APICON Medicine Update, 2009, Edited by A.K. Agarwal, vol. 19, part II: 950-954.
3. AuroViswabandya and Sachin Suresh Jadhav.Extracting maximum from cytogenetics in acute leukemia. Haematology Update, 2008, Edited by Prof. MB Agarwal.
4. Ezhilarasi Chendamarai, Ansu Abu Alex, Saravanan Ganesh, Kavitha M Lakshmi, Sachin Suresh Jadhav, MD, Biju George, MD, Aby Abraham, MD, Poonkuzhali Balasubramanian, PhD, Shaji Ramachandran, PhD, Alok Srivastava, MD and Vikram Mathews, MD. Evaluation of mechanisms of resistance to Arsenic Trioxide in patients with acute promeylocytic leukemia. Blood. Volume 116, Issue 21, 19 November 2010.
5. Madhura Gangaiah, Divya Patil, Sangeetha D R, Dr. Andhe Pallavi, Dr. Sachin Suresh Jadhav, Dr. Jayanthi Thumsi. A Handy Diagnostic Tool for Preventive Therapy based on Prior Estimation of Metastasis. International Journal of Science and Research. Volume 4 Issue 2, February 2015.
For Consultation
Dr. Sachin Jadhav, MD, DM (Clinical Hematology), holds the esteemed positions of Director of Hematology and Bone Marrow Transplantation (BMT) and Chairman of the International Hematology Consortium..
Copyright © 2024 . All rights reserved. Build with 🤍 by Digital GYB